Dexamethasone Sodium Phosphate

• Efficacy of peri-operative dexamethasone administration in single bundle anterior cruciate ligament reconstruction: a prospective randomized… Not authorised
  2024-511559-17-00 Phase IV 1 country Ospedale San Raffaele S.r.l.
• MELFLUFEN FOR ELDERLY PATIENTS WITH RELAPSED MYELOMA Not authorised
  2024-514652-33-00 Phase II 1 country Fondazione European Myeloma Network Italy O.N.L.U.S.
• SERRATUS : Evaluation of the Analgesia by Serratus Plane Block During Pleural Drainage in Intensive Care Unit. Pending
  2024-515722-83-00 Phase III 1 country Centre Hospitalier Universitaire Amiens Picardie
• A multi-center open-label phase 2 study of Ixazomib, Iberdomide and dexamethasone in elderly patients with multiple myeloma at first relapse Pending
  2024-516257-44-00 Phase II 1 country Centre Hospitalier Universitaire De Nantes
• Lantiolihaspuudutuksen vaikutus munuaisen poistoleikkauksen jälkeiseen kivun hoitoon ja toipumiseen Pending
  2024-519910-30-00 Phase IV 1 country Pirkanmaan hyvinvointialue
• Study of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL Pending
  2025-522019-40-00 Phase I/II 7 countries Novartis Pharma AG
• Comparison of low versus intermediate intravenous dexamethasone doses on rebound pain after ambulatory open foot surgery under popliteal sci… Pending
  2025-523356-31-01 Phase III/IV 1 country Hospital Universitario Dr Peset Aleixandre
• PHASE IB/II STUDY TO EVALUATE SAFETY AND PRELIMINARY EFFICACY OF ZANIDATAMAB IN COMBINATION WITH TUCATINIB AND CHEMOTHERAPY (CAPECITABINE OR… Pending
  2025-524613-89-00 Phase I/II 1 country Medica Scientia Innovation Research S.L.
• A study to compare Efficacy, Safety and How the Body Absorbs, Distributes, and Eliminates of Subcutaneous CT-P44 and Darzalex Faspro in Comb… Recruiting
  2024-518588-36-00 Phase III 2 countries Celltrion Inc.
• Evaluation of the omission of dexamethasone in premedication regimens during paclitaxel treatment Recruiting
  2023-507481-43-00 Phase III/IV 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
• A Ph2 Superiority Study with InO Monotherapy vs ALLR3 for Induction Treatment of Childhood HR ALL Recruiting
  2023-509810-13-00 Phase II 16 countries Pfizer Inc.
• Treatment of infants under one year with acute lymphoblastic leukemia according to the Interfant-21 protocol Recruiting
  2022-502503-30-00 Phase III 19 countries Princess Maxima Center For Pediatric Oncology
• The effect op corticosteroids on quality of life following total hip arthroplasty: HIPSTER study Recruiting
  2025-524368-39-00 Phase IV 1 country Ziekenhuis Oost Limburg
• A Phase 3 Study of a GPRC5D-directed CAR T Cell Therapy in Participants with Relapsed or Refractory Multiple Myeloma and Exposed to Lenalido… Recruiting
  2024-515279-37-00 Phase III 17 countries Celgene Corp.
• Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions (DEXA-REFINE) Recruiting
  2024-519759-27-00 Phase IV 1 country Consorcio Centro De Investigacion Biomedica En Red
• A proof-of-concept study to learn whether linvoseltamab can eliminate abnormal plasma cells that may lead to multiple myeloma in adult patie… Recruiting
  2023-505242-25-00 Phase II 6 countries Regeneron Pharmaceuticals Inc.
• A Trial to Learn if Linvoseltamab is Safe and Works in Adults with Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis) Recruiting
  2023-507809-34-00 Phase I/II 2 countries Regeneron Pharmaceuticals Inc.
• A study with new methods to monitor newly diagnosed multiple myeloma in participants being treated with a new treatment combination - TAURUS Recruiting
  2023-505221-14-00 Phase II 5 countries Emn Trial Office S.r.l. Impresa Sociale; European Myeloma Network B.V.
• RECOVERY Recruiting
  2023-507441-29-00 Phase III 9 countries University Of Oxford
• Trans-arterial treatment of patients with intra-hepatic cholangiocarcinoma not amenable to resection (TOMCAT) Recruiting
  2023-504433-50-00 Phase IV 1 country Oslo University Hospital HF
• Immunological variables associated to ICI toxicity in cancer patients Recruiting
  2023-505360-11-00 Phase II 1 country Institut Jules Bordet
• An Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evaluate the Efficacy and Safety of … Recruiting
  2024-518263-35-00 Phase II 1 country Hellenic Society Of Hematology
• Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma Recruiting
  2024-511454-45-00 Phase I (FiH) 2 countries Regeneron Pharmaceuticals Inc.
• Study to treat adult patients with Very High-Risk T-cell Acute Lymphoblastic Leukemia (ALL) with Daratumumab in addition to the National ALL… Ended
  2024-511627-34-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus

Showing 1–24 of 48 trials